BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20004054)

  • 1. Prognostication of upper tract urothelial carcinoma: what do we really need?
    Dalbagni G
    Eur Urol; 2010 Apr; 57(4):582-3; discussion 583-5. PubMed ID: 20004054
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
    Zigeuner R; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Weizer A; Kikuchi E; Remzi M; Raman JD; Bolenz C; Bensalah K; Capitanio U; Koppie TM; Kassouf W; Sircar K; Patard JJ; Fernández MI; Wood CG; Montorsi F; Ströbel P; Wheat JC; Haitel A; Oya M; Guo CC; Ng C; Chade DC; Sagalowsky A; Langner C
    Eur Urol; 2010 Apr; 57(4):575-81. PubMed ID: 19959276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy.
    Ouzzane A; Colin P; Xylinas E; Pignot G; Ariane MM; Saint F; Hoarau N; Adam E; Azemar MD; Bensadoun H; Cormier L; Cussenot O; Houlgatte A; Karsenty G; Bruyère F; Maurin C; Nouhaud FX; Phe V; Polguer T; Roumiguié M; Ruffion A; Rouprêt M;
    Eur Urol; 2011 Dec; 60(6):1258-65. PubMed ID: 21665356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S
    Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment.
    Weiss RE
    Urology; 2010 Feb; 75(2):333. PubMed ID: 20152483
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial comment.
    Shayegan B
    Urology; 2010 Feb; 75(2):332-3. PubMed ID: 20152482
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Hirano D; Okada Y; Nagane Y; Satoh K; Mochida J; Yamanaka Y; Hirakata H; Yamaguchi K; Kawata N; Takahashi S; Henmi A
    Urol Int; 2012; 89(1):71-7. PubMed ID: 22677699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial comment on: Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan.
    Patel HR
    Eur Urol; 2009 Jun; 55(6):1407. PubMed ID: 19299074
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
    Raman JD; Ng CK; Scherr DS; Margulis V; Lotan Y; Bensalah K; Patard JJ; Kikuchi E; Montorsi F; Zigeuner R; Weizer A; Bolenz C; Koppie TM; Isbarn H; Jeldres C; Kabbani W; Remzi M; Waldert M; Wood CG; Roscigno M; Oya M; Langner C; Wolf JS; Ströbel P; Fernández M; Karakiewcz P; Shariat SF
    Eur Urol; 2010 Jun; 57(6):1072-9. PubMed ID: 19619934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma.
    Wu CF; Pang ST; Chen CS; Chuang CK; Chen Y; Lin PY
    J Urol; 2007 Aug; 178(2):446-50, dicussion 450. PubMed ID: 17561129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma.
    Li WM; Shen JT; Li CC; Ke HL; Wei YC; Wu WJ; Chou YH; Huang CH
    Eur Urol; 2010 Jun; 57(6):963-9. PubMed ID: 20079965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
    Maulard-Durdux C; Dufour B; Hennequin C; Chrétien Y; Vignes B; Droz D; Delanian S; Housset M
    J Urol; 1996 Jan; 155(1):115-7. PubMed ID: 7490805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: impact on patient survival.
    Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2010 Oct; 17(10):848-54. PubMed ID: 20812922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS; Lee YH; Cho KS; Cho NH; Chung BH; Hong SJ
    Urology; 2010 Feb; 75(2):328-32. PubMed ID: 20018349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract.
    Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K
    J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
    Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF
    BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case records of the Massachusetts General Hospital. Case 30-2009. A 77-year-old man with recurrent transitional-cell carcinoma of the ureter.
    Kaufman DS; McDougal WS; Harisinghani MG; Wu CL
    N Engl J Med; 2009 Sep; 361(13):1292-9. PubMed ID: 19776411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.